Comparison of clinico-pathological characteristics and survival of recurrent ovarian cancer patients on seven different chemo-protocols Cover

.blurhash-client-img { display: none !important; }

Comparison of clinico-pathological characteristics and survival of recurrent ovarian cancer patients on seven different chemo-protocols

Acta Pharmaceutica

Volume 69 (2019): Issue 1 (March 2019)

By: Saima Sattar, Mobasher Ahmad, Hamid Saeed, Zikria Saleem, Zeeshan Danish and Muhammad Akhlaq

Open Access

|Dec 2018

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/acph-2019-0002 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 87 - 97

Accepted on: Jul 16, 2018

Published on: Dec 7, 2018

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

ovarian cancer,

carboplatin plus paclitaxel,

Related subjects:

Pharmacy, other

© 2018 Saima Sattar, Mobasher Ahmad, Hamid Saeed, Zikria Saleem, Zeeshan Danish, Muhammad Akhlaq, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 69 (2019): Issue 1 (March 2019)Next article